Published in Vaccine Weekly, June 11th, 2003
The development of the vaccine will be governed by a Collaborative Research and Development Agreement (CRADA). BioVex will provide an ImmunoVEX HIV vaccine construct to the VRC, which will test the vaccine in preclinical...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly